Biblio Discovery — Demo Discovery Service

53 results for "Epco Hasker"

Showing 1–20 · 0.24 seconds · RSS

  1. Journal Article Full text

    Monitoring drug effectiveness in kala-azar in Bihar, India: cost and feasibility of periodic random surveys versus a health service - based reporting system

    Paritosh, Malaviya; Singh, RP; Singh, SP et al.

    Trop Med Int Health · 2011 · English · PubMed Central

    BACKGROUND AND OBJECTIVE: Visceral leishmaniasis (VL) is a chronic infectious disease that is of major public health importance in the state of Bihar in India. A regional VL Elimination Initiative was launched in 2005 based on the use of the oral drug miltefosine. However, concerns were raised…

  2. Journal Article Full text

    Xenodiagnosis to address key questions in visceral leishmaniasis control and elimination

    Om Prakash Singh; Epco Hasker; Marleen Boelaert et al.

    PLOS Neglected Tropical Diseases, Vol. 14 No. 8 · 2020 · English · PLOS Scopus

    Visceral leishmaniasis (VL) remains an important public health issue worldwide causing substantial morbidity and mortality. The Indian subcontinent accounted for up to 90% of the global VL burden in the past but made significant progress during recent years and is now moving towards elimination…

  3. Journal Article Full text

    Assessing the Feasibility of an Intensified Extended Contact Survey (IECS) Compared to Passive Household Screening for Leprosy in Bangladesh

    Kazi Naher; Mahfuza Rifat; Dipak Kumar Biswas et al.

    Tropical Medicine and Infectious Disease, Vol. 10 No. 10 · 2025 · English · DOAJ Scopus

    Bangladesh is among the 23 WHO priority countries for leprosy, with a new case detection rate of 21 per million population including children among new cases indicating recent transmission. We aimed to compare active versus passive case detection using geospatial tools. A cluster-randomized study…

  4. Journal Article Full text

    Visceral leishmaniasis in Muzaffarpur district, Bihar, India from 1990 to 2008.

    Paritosh Malaviya; Albert Picado; Shri Prakash Singh et al.

    PLoS ONE, Vol. 6 No. 3 · 2011 · English · DOAJ Scopus

    Visceral Leishmaniasis (VL) is a vector-borne disease transmitted by Phlebotomus argentipes. To understand the VL seasonality, annual and monthly variations of VL incidence and its relationship to meteorological variables, the numbers of VL cases reported in Muzaffarpur district, Bihar, India from…

    Also available at: PLOS

  5. Journal Article Full text

    Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia.

    Bart Ostyn; Epco Hasker; Thomas P C Dorlo et al.

    PLoS ONE, Vol. 9 No. 6 · 2014 · English · DOAJ Scopus

    BACKGROUND:High frequency of relapse in miltefosine-treated visceral leishmaniasis (VL) patients in India and Nepal followed up for twelve months. OBJECTIVE:To identify epidemiological and clinical risk factors for relapse of VL in patients recently treated with standard dosing of miltefosine in…

    Also available at: PLOS

  6. Journal Article Full text

    Human African Trypanosomiasis Diagnosis in First-Line Health Services of Endemic Countries, a Systematic Review

    Patrick Mitashi; Epco Hasker; Veerle Lejon et al.

    PLoS Neglected Tropical Diseases, Vol. 6 No. 11 · 2012 · English · PLOS Scopus

    While the incidence of Human African Trypanosomiasis (HAT) is decreasing, the control approach is shifting from active population screening by mobile teams to passive case detection in primary care centers. We conducted a systematic review of the literature between 1970 and 2011 to assess which…

  7. Journal Article Full text

    Towards elimination: Challenges in community participation to a gHAT ‘screen and treat’ strategy using the new oral drug acoziborole in the Democratic Republic of the Congo

    Catiane Vander Kelen; Alain Mpanya; Ruth Nzuzi et al.

    PLOS Neglected Tropical Diseases, Vol. 19 No. 6 · 2025 · English · PLOS Scopus

    Until recently, treatment options for gambiense human African trypanosomiasis (gHAT) have been limited and toxic, negatively impacting community participation to screening and treatment. A new, non-toxic, single-dose oral drug has shown efficacy in a Phase III trial and is being tested in a trial…

  8. Journal Article Full text

    Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal.

    Albert Picado; Bart Ostyn; Shri Prakash Singh et al.

    PLoS ONE, Vol. 9 No. 1 · 2014 · English · DOAJ Scopus

    There is increasing interest in the role of asymptomatic infection in transmission of Visceral Leishmaniasis (VL). We studied the individual, household and environmental factors associated with asymptomatic Leishmania donovani infected individuals and VL. 7,538 individuals living in VL endemic…

    Also available at: PLOS

  9. Journal Article Full text

    Diagnosis of Visceral Leishmaniasis in an Elimination Setting: A Validation Study of the Diagnostic Algorithm in India

    Kristien Cloots; Om Prakash Singh; Abhishek Kumar Singh et al.

    Diagnostics, Vol. 12 No. 3 · 2022 · English · DOAJ Scopus

    Visceral leishmaniasis (VL) is on the verge of elimination on the Indian subcontinent. Nonetheless, the currently low VL-incidence setting brings along new challenges, one of which is the validity of the diagnostic algorithm, based on a combination of suggestive clinical symptoms in combination…

  10. Journal Article Full text

    Exposure to Phlebotomus argentipes (Diptera, Psychodidae, Phlebotominae) sand flies in rural areas of Bihar, India: the role of housing conditions.

    Paritosh Malaviya; Epco Hasker; Albert Picado et al.

    PLoS ONE, Vol. 9 No. 9 · 2014 · English · DOAJ Scopus

    BACKGROUND:Visceral Leishmaniasis (VL) is a vector-borne infectious disease, caused by the protozoan Leishmania donovani, which is transmitted by phlebotomine sand flies. In an earlier study in Bihar, India, we found an association between incidence of VL and housing conditions. In the current…

    Also available at: PLOS

  11. Journal Article Full text

    Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo

    Rian Snijders; Alain Fukinsia; Yves Claeys et al.

    PLOS Neglected Tropical Diseases, Vol. 14 No. 12 · 2020 · English · PLOS Scopus

    Background: Human African trypanosomiases caused by the Trypanosoma brucei gambiense parasite is a lethal disease targeted for eradication. One of the main disease control strategies is active case-finding through outreach campaigns. In 2014, a new method for active screening was developed with…

  12. Journal Article Full text

    Forecasting Human African Trypanosomiasis Prevalences from Population Screening Data Using Continuous Time Models.

    Harwin de Vries; Albert P M Wagelmans; Epco Hasker et al.

    PLoS Computational Biology, Vol. 12 No. 9 · 2016 · English · DOAJ Scopus

    To eliminate and eradicate gambiense human African trypanosomiasis (HAT), maximizing the effectiveness of active case finding is of key importance. The progression of the epidemic is largely influenced by the planning of these operations. This paper introduces and analyzes five models for…

  13. Journal Article Full text

    Community empowerment through participation in a tsetse control project in the Democratic Republic of Congo

    Catiane Vander Kelen; Alain Mpanya; Epco Hasker et al.

    PLOS Global Public Health, Vol. 3 No. 6 · 2023 · English · PLOS Scopus

    Gambiense Human African Trypanosomiasis (g-HAT) is a neglected tropical disease caused by trypanosomes transmitted by tsetse flies. In 2017, a pilot community-based project was launched in three villages in DRC with the overall goal of empowering community members to control tsetse using Tiny…

  14. Journal Article Full text

    Two-Year Follow-Up of Trypanosoma brucei gambiense Serology after Successful Treatment of Human African Trypanosomiasis: Results of Four Different Sero-Diagnostic Tests

    Raquel Inocencio da Luz; Sara Tablado Alonso; Philippe Büscher et al.

    Diagnostics, Vol. 12 No. 2 · 2022 · English · DOAJ Scopus

    Gambiense human African trypanosomiasis (gHAT), also known as gambiense sleeping sickness, is a parasitic infection caused by Trypanosoma brucei gambiense. During the last decades, gHAT incidence has been brought to an all-time low. Newly developed serological tools and drugs for its diagnosis and…